The effect of allopurinol on cardiovascular outcomes in patients with type 2 diabetes: a systematic review

E Bletsa, SA Paschou, V Tsigkou, PK Stampouloglou… - Hormones, 2022 - Springer
Background Cardiovascular disease (CVD) remains the main cause of death in patients with
type 2 diabetes (T2D). Although hyperuricemia has been associated with multiple CV …
被引用次数：4 相关文章

The effect of allopurinol on cardiovascular outcomes in patients with type 2 diabetes: a systematic review.

E Bletsa, SA Paschou, V Tsigkou… - Hormones (Athens …, 2022 - europepmc.org
Background Cardiovascular disease (CVD) remains the main cause of death in patients with
type 2 diabetes (T2D). Although hyperuricemia has been associated with multiple CV …

The effect of allopurinol on cardiovascular outcomes in patients with type 2 diabetes: a systematic review

E Bletsa, SA Paschou, V Tsigkou… - Hormones (Athens …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Cardiovascular disease (CVD) remains the main cause of death in patients with
type 2 diabetes (T2D). Although hyperuricemia has been associated with multiple CV …